Username or email Reset password
Vitamin A (as Beta Carotene), Vitamin C (Ascorbic Acid), Vitamin D (as Cholecalciferol), Vitamin E (as D-Alpha Tocopherol Acetate), Thiamin (as Thiamine Hydrochloride), Riboflavin, Niacin (as Niacinamide), Vitamin B6 (as Pyridoxine Hydrochloride), Folate (as Calcium L-5-Methyltetrahydrofolate), Vitamin B12 (as Methylcobalamin), Biotin (as Magnesium Biotinate), Pantothenic Acid (as D-Calcium Pantothenate), Choline (as Choline Bitartrate), Zinc (as Zinc Citrate), Chromium (as Chromium Picolinate), Lustriva (Inositol-stabilized Arginine Silicate, Magnesium Biotinate), Inositol, Methylsulfonylmethane, Proprietary Branched Chain Amino Acid Complex (L-Leucine, L-Isoleucine, L-Valine), Betaine, Hesperidin
How do I book
Defining the correlation between immune-checkpoint inhibitors-related adverse events and clinical outcomes: a narrative review Omar Abdihamid 1 , Abeid Omar 2 and Tibera Rugambwa 3 1 Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, Peoples Republic of China 2 Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Alexandria University, Champlion Street, Alazarita, Alexandria 21131, Egypt 3 Department of Internal Medicine, Mbeya Zonal Referral Hospital, Mbeya 419, Tanzania Abstract Immune checkpoint inhibitors (ICIs) have increased modern anticancer armamentarium portfolios, with 15%60% of cancer patients deriving clinical benefit while others progress, including some occurrences of accelerated progressions
